arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Enovis Corporation

ENOV Health Care Industrial Specialties
$18.82
▲ +1.5% Today
as of Sep 4, 16:48 ET
Last 30 days -37.13% Jul 28 → Sep 04
$17.53 $21.26 $24.99 $28.72 $32.45 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$19.01
High
$19.32
Low
$18.52
Volume
$2M
Avg Vol
$1M
Mkt Cap
$1.5B
P/E (TTM)
—
Beta
—
52w High
$34.28
52w Low
$18.52
Div Yield
—
Shares Out
$58M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 16:46 StockStory
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Sep 4 · 07:06 Simply Wall St.
Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure
Sep 3 · 16:00 Zacks
What Makes Enovis (ENOV) a New Buy Stock
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$19
$34
2% of range
Avg surprise (last 3)
+8.3%
Avg reaction (last 2)
+3.1%
50% positive
Latest IV / EM
155%
EM ±24.2% · $18 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-9.99$-7.27$-4.55$-1.83$0.89 Actual $-0.43Actual $-0.18Actual $-0.05Actual $-1.32Actual $-0.34Actual $-0.58Actual $0.81Est $0.74Actual $0.79Est $0.74Actual $-9.99Actual $0.89Est $0.82Actual $-0.02 MarJunSepMarJunSepMar/2025Jun/2025OctMar/2026Jul
Revenue vs Net Income Revenue Net income
$-571M$-274M$24M$321M$619M Sep 24Apr 25Jul 25Oct 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 3, 2026Jul 2026 $-0.02 — — — — financials
Thu May 7, 2026Mar/2026 $0.89 $0.82 +8.5% +9.9% +9.7% earnings
Fri Oct 3, 2025Oct 2025 $-9.99 — — — — financials
Thu Aug 7, 2025Jun/2025 $0.79 $0.74 +6.8% — — earnings
Thu May 8, 2025Mar/2025 $0.81 $0.74 +9.5% — -3.4% earnings
Fri Sep 27, 2024Sep 2024 $-0.58 — — — — financials
Fri Jun 28, 2024Jun 2024 $-0.34 — — — — financials
Fri Mar 29, 2024Mar 2024 $-1.32 — — — — financials
Fri Sep 29, 2023Sep 2023 $-0.05 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.18 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Dec 2025Oct 2025Jul 2025Apr 2025Dec 2024Sep 2024
Revenue$583M$589M—$549M$565M$559M—$505M
Cost of revenue$224M$224M—$220M$230M$227M—$219M
Gross profit$359M$365M—$329M$335M$332M—$286M
Operating income$17M$7M—$-558M$-17M$-47M—$-32M
Net income$-1M$-8M—$-571M$-37M$-56M—$-32M
EPS (diluted)$-0.02$-0.15—$-9.99$-0.64$-0.98—$-0.58

Balance sheet (quarterly)

MetricJul 2026Apr 2026Dec 2025Oct 2025Jul 2025Apr 2025Dec 2024Sep 2024
Cash & equivalents$13M$33M$36M$34M$44M$38M$48M$35M
Inventory$602M$603M$584M$614M$628M$586M$547M$610M
Total current assets$1.21B$1.24B$1.21B$1.28B$1.28B$1.22B$1.15B$1.20B
Total assets$3.77B$3.83B$3.83B$4.43B$5.02B$4.88B$4.72B$5.55B
Long-term debt$1.25B$1.29B$1.26B$1.34B$1.37B$1.37B$1.31B$1.33B
Total liabilities$2.29B$2.35B$2.34B$2.41B$2.44B$2.25B$2.15B$2.22B
Total equity$1.48B$1.48B$1.49B$2.02B$2.58B$2.62B$2.56B$3.33B

Implied volatility — last 90 days

45%142%240%337%435% Jun 07 — IV 88% · EM ±12.2%Jun 08 — IV 85% · EM ±11.2%Jun 09 — IV 80% · EM ±10.0%Jun 10 — IV 120% · EM ±14.2%Jun 11 — IV 99% · EM ±10.9%Jun 12 — IV 121% · EM ±12.4%Jun 15 — IV 152% · EM ±11.0%Jun 16 — IV 188% · EM ±11.1%Jun 19 — IV 82% · EM ±18.1%Jun 22 — IV 73% · EM ±15.1%Jun 23 — IV 78% · EM ±16.0%Jun 24 — IV 70% · EM ±14.0%Jun 25 — IV 79% · EM ±15.6%Jun 26 — IV 63% · EM ±12.0%Jun 29 — IV 101% · EM ±17.9%Jun 30 — IV 72% · EM ±12.4%Jul 01 — IV 101% · EM ±16.8%Jul 02 — IV 74% · EM ±11.9%Jul 03 — IV 80% · EM ±12.4%Jul 06 — IV 95% · EM ±13.1%Jul 07 — IV 82% · EM ±10.9%Jul 08 — IV 96% · EM ±12.1%Jul 09 — IV 68% · EM ±8.0%Jul 10 — IV 97% · EM ±10.7%Jul 13 — IV 111% · EM ±9.2%Jul 14 — IV 112% · EM ±8.1%Jul 15 — IV 98% · EM ±5.8%Jul 16 — IV 435% · EM ±18.2%Jul 20 — IV 76% · EM ±17.9%Jul 21 — IV 83% · EM ±19.3%Jul 22 — IV 80% · EM ±18.4%Jul 23 — IV 79% · EM ±17.7%Jul 24 — IV 90% · EM ±19.8%Jul 27 — IV 89% · EM ±18.5%Jul 28 — IV 78% · EM ±15.9%Jul 29 — IV 80% · EM ±15.9%Jul 30 — IV 77% · EM ±15.0%Jul 31 — IV 82% · EM ±15.8%Aug 03 — IV 90% · EM ±15.9%Aug 04 — IV 81% · EM ±14.0%Aug 05 — IV 87% · EM ±14.5%Aug 06 — IV 83% · EM ±13.5%Aug 07 — IV 63% · EM ±9.9%Aug 10 — IV 75% · EM ±10.4%Aug 11 — IV 55% · EM ±7.2%Aug 12 — IV 82% · EM ±10.2%Aug 13 — IV 66% · EM ±7.8%Aug 14 — IV 92% · EM ±10.2%Aug 17 — IV 73% · EM ±6.1%Aug 18 — IV 74% · EM ±5.4%Aug 19 — IV 201% · EM ±11.9%Aug 20 — IV 279% · EM ±11.7%Aug 24 — IV 60% · EM ±12.6%Aug 25 — IV 50% · EM ±10.3%Aug 26 — IV 73% · EM ±14.6%Aug 27 — IV 52% · EM ±10.3%Aug 28 — IV 46% · EM ±8.7%Aug 31 — IV 57% · EM ±10.1%Sep 01 — IV 86% · EM ±14.9%Sep 02 — IV 65% · EM ±10.9%Sep 03 — IV 84% · EM ±13.7%Sep 04 — IV 155% · EM ±24.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in